Clinical Trials
26 trialsNCT00704626 2026-05-18
SAA
University of California, Davis
Enrolling by invitation
NCT06680037 2026-05-18
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
TG Therapeutics, Inc.
Phase 1 Recruiting
NCT07593911 2026-05-18
ArchAid-002
Beijing GoBroad Hospital
Phase NA Not yet recruiting
NCT03816345 2026-05-13
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
Phase 1 Recruiting
NCT07337785 2026-05-12
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Tongji Hospital
Phase EARLY_PHASE1 Recruiting
NCT07526493 2026-05-12
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Tongji Hospital
Phase 1 Recruiting
NCT07002034 2026-05-06
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Reunion Neuroscience Inc
Phase 2 Recruiting
NCT07085676 2026-05-06
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Hadassah Medical Organization
Phase 1 Recruiting
NCT07304154 2026-04-21
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Gilead Sciences
Phase 1 Recruiting
NCT05819008 2026-04-01
Remote Neuropsychological Assessment of Patients With Neurological Disorders and Injuries
Umeå University
Recruiting
NCT05057676 2026-03-11
AIM
University of Iowa
Phase NA Recruiting
NCT07392528 2026-02-11
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/ BCMA(QT-019C) in Patients With r/ r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT06220201 2026-02-10
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 1 Recruiting
NCT04806620 2026-01-22
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Recruiting
NCT07333196 2026-01-21
Tongji NADs Cohort
Tongji Hospital
Not yet recruiting
NCT04306939 2026-01-07
GREAT1
University of Pittsburgh
Suspended
NCT06788886 2025-12-30
Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases
Mayo Clinic
Phase NA Recruiting
NCT06322342 2025-12-26
Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent
Reveal Pharmaceuticals Inc.
Phase 2 Completed
NCT04952766 2025-12-23
EREVA
Centre Hospitalier Régional d'Orléans
Phase 4 Completed
NCT06939166 2025-12-15
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Phase EARLY_PHASE1 Recruiting
NCT00445367 2025-10-02
Biobank For MS And Other Demyelinating Diseases
Accelerated Cure Project for Multiple Sclerosis
Active not recruiting
NCT02670161 2025-08-24
Quality Improvement and Practice Based Research in Neurology Using the EMR
Endeavor Health
Phase 4 Enrolling by invitation
NCT04721717 2025-08-08
AIM's Writing for Healing: A Workshop for Individuals Living With Paralysis
University of Alabama at Birmingham
Recruiting
NCT04031469 2025-07-31
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease
ProgenaBiome
Suspended
NCT06249438 2025-07-25
CAR-AID
RenJi Hospital
Phase 1 Recruiting
NCT06869278 2025-06-11
A Study of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1 Recruiting